Value Based Care and the 30 Day Clock: What it Means for LTACHs

A Clock That Doesn’t Stop at Discharge

For many years, the hospital’s financial responsibility for a patient effectively ended at discharge. The recent shift from Fee-for-Service (FFS) models to Value-Based Care within Medicare’s Shared Savings Program including bundled payment models (BPCI, ACOs, TEAM) has changed that. Under programs tied to value-based care, a hospital remains financially accountable for a patient’s total cost and quality of care for anywhere from 30 to 90 days post-discharge, regardless of the patient’s next site of care. That single shift has significantly impacted the relationship dynamics between hospitals and their post-acute partners.

My View from the Operational Side

Earlier in my career, I worked on the operational side of a Medicare convener, managing ACO tracks and BPCI bundles. From that seat, the math was clear: a hospital’s outcomes were only ever as good as the post-acute care that patients received afterward. A well-planned surgery followed by a poorly coordinated transition of care would drastically increase an episode’s cost and decrease quality metrics, which then resulted in poorer outcomes at the 30, 60, and 90-day marks. In the end, the hospital didn’t stop being on the hook just because the patient was no longer in their building.

Why Strategic Post-Acute Partnerships Are the Real Lever

Hospitals spend enormous amounts of time and energy optimizing their own internal processes, such as surgical protocols, length of stay, clinical pathways, and readmission reduction strategies, while treating their post-acute network as a list of vetted vendors rather than a strategic asset. That’s a mismatch. If 20–40% of an episode’s cost and risk lives in the post-acute period, then the post-acute partner isn’t a downstream detail but rather one of the highest-leverage relationships a hospital has. It gives opportunities for collaboration and shared ownership of outcomes.

A strategic partnership looks different from a standard referral relationship in a few ways:

• Joint performance review, not just a discharge handoff. The partnerships that make lasting impacts are the ones where both sides treat the patient’s outcome as a shared responsibility, not just a report or hand-off at the hospital doors. It’s easy to sign a data-sharing agreement and still operate like two separate organizations, that’s not ownership, it’s risk management. Joint ownership includes hospitals and their high-volume downstream partners sitting down regularly in joint operations committee (JOC) meetings to review shared readmission and outcome data, rather than waiting for a quarterly report to surface a problem. Committee members must also consider what went well within the episode and whether that success can be translated to other areas of care, as well as what pain points need to be addressed operationally before they become larger issues.
• Early involvement in program design and intentional referral placement. Post-acute partners can flag capability gaps or capacity constraints before a value-based contract commits a hospital to volume it can’t safely place. This also includes ensuring that post-acute providers offer a wide range of services and that patients are educated by their healthcare teams to make an informed decision about their post-acute care. One provider may excel in respiratory care while another has better cardiovascular outcomes, and patients should be referred to whichever best meets their individual needs that episode.
• A small number of deep relationships instead of a long list of shallow ones. Networks built on trust and shared data outperform networks built purely on bed availability and quick transitions of care. It’s one thing to discharge to the next site of care quickly and efficiently, but if the hand-off isn’t thorough and the SNF or Home Health team doesn’t have all the information they need to adequately care for the patient, the risk of bouncing back to the hospital is high.

The Cost Case for Transferring Earlier

The longer a medically complex patient stays in an acute care hospital past the point where LTACH-level care would serve them just as well, the more the total episode cost climbs, often without a matching improvement in outcome. ICU and acute med-surg days are the most expensive days in an entire episode. A patient who is stable enough for LTACH care but remains in an acute bed for a few extra days “just to be safe” isn’t accumulating better outcomes during that time but rather they’re accumulating cost, which is where many hospitals struggle when shifting away from fee-for-service.

Earlier identification and transfer changes that math directly. It shifts high-acuity days out of the most expensive setting and into a level of care purpose-built to match the patient’s needs at this stage of recovery. LTACHs deliver that same ventilator weaning, complex wound management, and recovery care at a fraction of the daily cost, without asking the patient to step down the level of care they’re receiving sooner than they’re ready for. LTACHs can then align their post-acute partnerships with those of their hospital partners to seamlessly hand off the patient to a SNF or Home Health for continued rehabilitation and recovery. This allows the referring hospital to maintain joint ownership and visibility into the patient’s care, resulting in better overall outcomes and seamless transitions of care. Patients don’t get lost in the system or experience delays when transitioning between care levels.

Why VBC and Insurers Should Actively Leverage the LTACH Benefit

Often the LTACH benefit gets treated as a niche, high-cost carve-out to be managed cautiously rather than a lever to be used deliberately. From where I sit, that’s a misconception, for a few reasons:

• It’s cheaper than the alternative, not more expensive. Compared to extended acute or ICU stays, LTACH care for the same clinical population is typically the lower-cost option per day. The “expensive” perception comes from comparing it to SNF rates, not to what the patient’s care would otherwise sit costwise.
• It reduces downstream risk. Patients who step down through an LTACH when their acuity calls for it are less likely to bounce back to acute care than patients pushed into a lower level of care too soon. LTACHs have critical care physicians and specialists on site continually to manage any changes in a patient’s condition, and patients can be upgraded or downgraded between ICU, telemetry, and med-surg beds to meet their needs at any given moment, reducing the need to send them out to a higher level of care. An LTACH stay is also a period where the patient can continue to stabilize before being admitted to a SNF, further reducing 30, 60, and 90-day readmission rates.
• It supports the metrics payers and VBC contracts are already accountable for. Under bundled and value-based arrangements, insurers share in the total cost and quality outcome of the episode. Underutilizing the LTACH benefit for patients who need it doesn’t avoid that cost but rather, it just relocates it to a more expensive setting or a preventable readmission.
• Earlier authorization enables earlier transfer. Much of the delay in moving a “ready” patient into LTACH care isn’t clinical, it’s administrative. Payers who streamline authorization for well-matched LTACH candidates directly enable the earlier transfers that reduce total episode cost. Days spent waiting for authorizations or peer-to-peer calls can quickly and unnecessarily escalate the cost of care.

Used proactively rather than defensively, the LTACH benefit isn’t a cost center to be minimized. It’s one of the more effective tools payers have for managing both cost and outcomes in exactly the population that drives the most variation in both.

LTACHs Fill a Role Nothing Else in the Continuum of Care Can

Some post-acute providers see bundled payments as one more way to be scrutinized for costs outside their control. I’d argue it’s the opposite, it’s an opportunity for LTACHs to prove a value that used to be invisible in fee-for-service thinking.

LTACHs exist for a specific reason: patients who are medically too complex or unstable for a lower level of care, but who need a longer time at a slower pace to recover. These complex patients require a level of care that many SNFs aren’t equipped to provide, and that an acute hospital doesn’t need to keep providing, especially where length of stay is closely monitored. Without that middle tier, patients either stay in an ICU bed longer than necessary, or they get discharged to a setting that can’t manage their acuity, driving up readmissions. Either outcome is exactly what value-based models are designed to avoid.

That makes the LTACH’s role in the continuum less like “one more site of care” and more like a pressure-release valve for hospital ICU and step-down units. When patients remain in the ICU longer than needed, it causes backups in the emergency department, since the ED needs those critical care beds too, affecting hospital throughput and operations and ultimately driving up episode cost and hospital expense. When LTACHs can show a hospital that early transition results in lower readmission rates, shorter overall acute length of stay for the referring hospital, and better functional outcomes, they’re not just a discharge destination but an essential partner.

Where This Is Headed

As value-based models continue to expand in scope and the number of patients they serve, the LTACHs that invest now in data transparency, condition-specific protocols, and real collaboration with referring hospitals will be the ones hospitals actively seek out. Not because they’re the closest or have the most bed availability, but because they can be trusted with a complex patient whose 30-day clock is running, a clock both organizations are now watching together.